Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib.
CONCLUSIONS Celastrol enhances the antitumor activity of sorafenib in HCC tumor cells by suppressing the AKT pathway and VEGF autocrine system.
PMID: 31152143 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Hepatocellular Carcinoma | Liver | Liver Cancer | Research | Science | Thunder God Vine | Urology & Nephrology